News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Santen Pharmaceutical to Buy Novagali Pharma for $136 Million


9/28/2011 6:50:17 AM

Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French eye care company Novagali from its main shareholders, followed by a tender offer for the rest of the company. Santen, which expects to pay about 100 million euros($136 million)for the entire company, says on its website that it is the leader in Japan for prescription ophthalmics with a market share of nearly 40 percent, but it is also present in anti-rheumatic drugs. Novagali shareholders Edmond de Rothschild Investment Partners, Auriga Partners, IdInvest Partners and CDC Innovation have agreed to sell their shares at 6.15 euros each -- a 71.3 percent premium to Novagali's closing share price on Sept. 27. Novagali said.

Read at Reuters
Read at Bloomberg
Read at News Release
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES